NeuroMetrix, Inc.
NURO
$4.34
-$0.035-0.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -48.61% | -41.41% | -39.08% | -31.36% | -28.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -48.61% | -41.41% | -39.08% | -31.36% | -28.52% |
| Cost of Revenue | -32.37% | -25.42% | -27.82% | -21.82% | -22.02% |
| Gross Profit | -56.65% | -49.18% | -44.63% | -36.03% | -31.35% |
| SG&A Expenses | 0.44% | 5.36% | 13.61% | 16.40% | 14.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.93% | -5.67% | -3.02% | 1.65% | 0.42% |
| Operating Income | -14.68% | -31.71% | -40.95% | -47.82% | -50.82% |
| Income Before Tax | -19.55% | -37.75% | -46.70% | -58.67% | -47.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.55% | -37.75% | -46.70% | -58.67% | -47.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.55% | -37.75% | -46.70% | -58.67% | -47.83% |
| EBIT | -14.68% | -31.71% | -40.95% | -47.82% | -50.82% |
| EBITDA | -14.26% | -30.98% | -40.55% | -47.80% | -51.22% |
| EPS Basic | 35.87% | 17.71% | 4.25% | -14.59% | -25.91% |
| Normalized Basic EPS | 38.47% | 17.74% | 1.25% | -14.74% | -32.49% |
| EPS Diluted | 35.87% | 17.77% | 4.32% | -14.49% | -25.67% |
| Normalized Diluted EPS | 38.47% | 17.74% | 1.25% | -14.74% | -32.49% |
| Average Basic Shares Outstanding | 89.14% | 75.96% | 59.41% | 36.58% | 16.62% |
| Average Diluted Shares Outstanding | 89.14% | 75.96% | 59.41% | 36.58% | 16.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |